|
|
|
Insider
Information: |
Monia Brett P |
Relationship: |
Director |
City: |
Carlsbad |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
188,789 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$7,084,848 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
188,789 |
|
|
Total
Value |
$7,084,848 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
9
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
7
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-81.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
Cognition Therapeutics Inc |
CGTX |
Director |
2024-06-07 |
14,500 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2024-02-16 |
4 |
S |
$44.49 |
$17,219 |
D/D |
(387) |
173,751 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2021-02-26 |
4 |
A |
$44.54 |
$11,001 |
D/D |
247 |
50,350 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
|
2019-07-01 |
4 |
A |
$45.70 |
$7,907 |
D/D |
173 |
22,444 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-10-12 |
4 |
AS |
$46.00 |
$173,420 |
D/D |
(3,770) |
118,111 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2017-01-17 |
4 |
S |
$46.29 |
$115,819 |
D/D |
(2,502) |
11,772 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
|
2018-07-24 |
4 |
AS |
$47.03 |
$7,337 |
D/D |
(156) |
15,841 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2014-01-16 |
4 |
S |
$47.08 |
$38,653 |
D/D |
(821) |
1,816 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-12-14 |
4 |
OE |
$47.34 |
$1,136,160 |
D/D |
24,000 |
127,251 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-12-20 |
4 |
OE |
$47.34 |
$307,710 |
D/D |
6,500 |
124,611 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-12-21 |
4 |
OE |
$47.34 |
$828,450 |
D/D |
17,500 |
135,611 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2016-01-01 |
4 |
A |
$47.71 |
$6,202 |
D/D |
130 |
4,485 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2015-07-01 |
4 |
A |
$48.59 |
$6,170 |
D/D |
127 |
4,553 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2017-01-03 |
4 |
AS |
$48.60 |
$15,017 |
D/D |
(309) |
7,872 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-12-14 |
4 |
S |
$49.21 |
$1,190,019 |
D/D |
(24,000) |
118,111 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-12-21 |
4 |
S |
$49.29 |
$862,577 |
D/D |
(17,500) |
118,111 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2024-02-02 |
4 |
S |
$49.37 |
$1,160,303 |
D/D |
(23,501) |
174,138 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-12-20 |
4 |
S |
$49.64 |
$322,643 |
D/D |
(6,500) |
118,111 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2018-01-02 |
4 |
AS |
$50.00 |
$8,150 |
D/D |
(163) |
11,619 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2024-01-17 |
4 |
S |
$50.42 |
$1,616,319 |
D/D |
(32,059) |
154,136 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2020-12-04 |
4 |
AS |
$51.04 |
$1,216,794 |
D/D |
(23,840) |
28,879 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2020-12-02 |
4 |
AS |
$51.32 |
$1,085,931 |
D/D |
(21,160) |
28,879 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2017-07-03 |
4 |
AS |
$51.35 |
$15,867 |
D/D |
(309) |
11,626 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
|
2024-01-25 |
4 |
S |
$51.75 |
$118,249 |
D/D |
(2,285) |
151,851 |
0 |
% |
|
IONS |
Ionis Pharmaceuticals Inc |
COO |
|
2018-01-16 |
4 |
S |
$51.76 |
$146,015 |
D/D |
(2,821) |
15,783 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
|
2016-12-20 |
4 |
AS |
$52.48 |
$6,822 |
D/D |
(130) |
7,872 |
0 |
- |
|
117 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|